Canada markets closed

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5040-0.0098 (-1.91%)
At close: 04:00PM EDT
0.5138 +0.01 (+1.94%)
After hours: 07:54PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
5,533
7,338
20,948
0
6
Cost of Revenue
5,559
7,380
9,163
-
-
Gross Profit
-26
-42
11,785
-
-
Operating Expenses
Research Development
48,061
68,889
52,975
43,859
21,474
Selling General and Administrative
17,871
18,963
16,180
13,418
12,354
Total Operating Expenses
65,932
87,852
69,155
57,277
33,828
Operating Income or Loss
-65,958
-87,894
-57,370
-57,277
-33,822
Total Other Income/Expenses Net
57,389
-78
568
-46
1,538
Income Before Tax
-8,471
-87,933
-56,241
-55,178
-30,055
Income from Continuing Operations
-8,471
-87,933
-56,241
-55,178
-30,055
Net Income
-8,471
-87,933
-56,241
-55,178
-30,055
Net Income available to common shareholders
-8,471
-87,933
-56,241
-55,178
-30,055
Basic EPS
-
-2.87
-2.93
-4.60
-2.68
Diluted EPS
-
-2.87
-2.93
-4.60
-2.68
Basic Average Shares
-
30,641
19,179
12,004
11,214
Diluted Average Shares
-
30,641
19,179
12,004
11,214
EBITDA
-
-87,604
-57,232
-57,131
-33,673